Adare Pharma Solutions is a global technology-driven contract development and manufacturing organization (CDMO) that provides integrated product development, commercial manufacturing, and packaging services for small-molecule oral dosage forms for the pharmaceutical industry.
The company provides contract development and manufacturing services spanning clinical trial materials, product development, commercial manufacturing, and packaging. It develops and manufactures oral dose products from beginning to end, and can bring pre-established projects into its facilities through technology transfer.
Adare's specialized technology platforms address taste masking, customized release, multiparticulate systems, and patient-centric dosing solutions. Its work encompasses formulation development and analytical services for oral drug products.
It serves pharmaceutical and biotechnology companies, generic drug manufacturers, clinical trial sponsors, and contract research organizations, with services that support teams developing small-molecule medicines and advancing oral dosage products from clinical trial materials to commercial supply.
The company also works with organizations that need commercial packaging and serialization as part of a CDMO program. These capabilities support oral product programs across development and commercial stages.
Adare has facilities in the US and Europe. The facilities have developed and manufactured more than 65 products sold by customers worldwide, reflecting the company's history in drug delivery and its focus on oral dosage forms.